A new trading day began on Friday, with Ekso Bionics Holdings Inc (NASDAQ: EKSO) stock price down -9.26% from the previous day of trading, before settling in for the closing price of $8.64. EKSO’s price has ranged from $2.73 to $14.97 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 25.99% over the past five years. Meanwhile, its annual earnings per share averaged 74.46%. With a float of $3.13 million, this company’s outstanding shares have now reached $3.39 million.
Ekso Bionics Holdings Inc (EKSO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Ekso Bionics Holdings Inc is 7.65%, while institutional ownership is 10.56%. The most recent insider transaction that took place on Dec 09 ’25, was worth 1,269. In this transaction Chief Operating Officer of this company sold 270 shares at a rate of $4.70, taking the stock ownership to the 26,941 shares. Before that another transaction happened on Dec 09 ’25, when Company’s Chief Financial Officer sold 1,238 for $4.70, making the entire transaction worth $5,819. This insider now owns 24,771 shares in total.
Ekso Bionics Holdings Inc (EKSO) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -2.1 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 74.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 80.74% during the next five years compared to 25.99% growth over the previous five years of trading.
Ekso Bionics Holdings Inc (NASDAQ: EKSO) Trading Performance Indicators
Here are Ekso Bionics Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.57, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Ekso Bionics Holdings Inc (EKSO)
As of the previous 9 days, the stock’s Stochastic %D was 46.06%.
During the past 100 days, Ekso Bionics Holdings Inc’s (EKSO) raw stochastic average was set at 50.31%, which indicates a significant increase from 40.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.76 in the past 14 days, which was higher than the 0.41 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.03, while its 200-day Moving Average is $4.78. Nevertheless, the first resistance level for the watch stands at $8.64 in the near term. At $9.44, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.01. If the price goes on to break the first support level at $7.27, it is likely to go to the next support level at $6.70. The third support level lies at $5.90 if the price breaches the second support level.
Ekso Bionics Holdings Inc (NASDAQ: EKSO) Key Stats
With a market capitalization of 26.60 million, the company has a total of 2,623K Shares Outstanding. Currently, annual sales are 17,930 K while annual income is -11,330 K. The company’s previous quarter sales were 4,230 K while its latest quarter income was -1,420 K.
